Company / PP&E per Share
Outlook Therapeutics, Inc. PP&E per Share History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2020
5-year range
$0.01 / $0.74
FY2016-FY2020
Trend
-96.7%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.74 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2020 with a 3-year CAGR of -74.7%.
Declined from $0.74 to $0.01 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -74.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, pp&e per share decreased 96.7% year-over-year.
- Peak pp&e per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2020 | $0.01 | -96.7% |
| FY2019 | $0.35 | -52.6% |
| FY2018 | $0.74 | +5.1% |
| FY2017 | $0.71 | -60.7% |
| FY2016 | $1.80 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026